Compare CYTK & SWKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CYTK | SWKS |
|---|---|---|
| Founded | 1997 | 1962 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.4B | 9.0B |
| IPO Year | 2004 | 1995 |
| Metric | CYTK | SWKS |
|---|---|---|
| Price | $69.27 | $72.76 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 19 | 15 |
| Target Price | ★ $89.26 | $70.38 |
| AVG Volume (30 Days) | 1.7M | ★ 4.7M |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 4.53% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.76 |
| Revenue | $13,368,000.00 | ★ $4,086,900,000.00 |
| Revenue This Year | $7.37 | N/A |
| Revenue Next Year | $310.19 | $3.06 |
| P/E Ratio | ★ N/A | $92.49 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $31.99 | $51.93 |
| 52 Week High | $80.20 | $90.90 |
| Indicator | CYTK | SWKS |
|---|---|---|
| Relative Strength Index (RSI) | 45.21 | 49.83 |
| Support Level | $59.07 | $70.45 |
| Resistance Level | $70.69 | $74.83 |
| Average True Range (ATR) | 2.87 | 5.07 |
| MACD | -1.15 | -1.29 |
| Stochastic Oscillator | 25.26 | 21.42 |
Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
Skyworks Solutions produces semiconductors for wireless handsets and other devices that are used to enable wireless connectivity. Its main products include power amplifiers, filters, switches, and integrated front-end modules that support wireless transmissions. Skyworks' customers are mostly large smartphone manufacturers, but the firm also has a growing presence in nonhandset applications such as wireless routers, medical devices, and automobiles.